VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · IEX Real-Time Price · USD
2.130
-0.020 (-0.93%)
At close: Jul 19, 2024, 4:30 PM
2.150
+0.020 (0.94%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $30.95 million as of July 22, 2024. Its market cap has increased by 125.88% in one year.
Market Cap
30.95M
Enterprise Value
-54.88M
1-Year Change
125.88%
Ranking
Category
Stock Price
$2.13
Market Cap Chart
Since January 25, 2018, VYNE Therapeutics's market cap has decreased from $615.20M to $30.95M, a decrease of -94.97%. That is a compound annual growth rate of -36.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 30.90M | -4.92% |
| Dec 29, 2023 | 32.50M | 273.56% |
| Dec 30, 2022 | 8.70M | -84.07% |
| Dec 31, 2021 | 54.60M | -79.41% |
| Dec 31, 2020 | 265.20M | 138.27% |
| Dec 31, 2019 | 111.30M | 16.30% |
| Dec 31, 2018 | 95.70M | -84.44% |
| Jan 25, 2018 | 615.20M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quince Therapeutics | 32.41M |
| IRIDEX | 32.34M |
| Cutera | 31.96M |
| Longeveron | 31.59M |
| Reviva Pharmaceuticals Holdings | 31.31M |
| SeaStar Medical Holding | 30.73M |
| Equillium | 30.67M |
| NKGen Biotech | 30.67M |